EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EffRx Pharmaceuticals SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3297
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EffRx Pharmaceuticals SA (EffRx), formerly EffRx Inc is a pharmaceutical company that develops and commercializes prescription medications for specialty indications. The company offers therapeutics for men and women with musculoskeletal, genitourinary and endocrine disorders. It provides commercialized product Binosto, an effervescent tablet for oral solution and treatment of osteoporosis in postmenopausal women. EffRx’s lead development product, EX404 targets polycystic ovarian syndrome in adolescents. The company also offers life cycle management services to pharmaceutical and biotechnology companies. It distributes products through distributors in the US, Australia, South Korea and others. EffRx is headquartered in Schwyz, Switzerland.

EffRx Pharmaceuticals SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
EffRx Pharma Raises USD2.3 Million in Venture financing 12
Private Equity 13
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 13
Partnerships 15
EffRx Pharma Enters into Agreement with Andrus 15
EffRx Pharma Enters into Distribution Agreement with Andrus for Binosto 16
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 17
EffRx Pharma Enters An Agreement With Kadmon 18
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 19
Lacer Enters Into Distribution Agreement With EffRx For Binosto 20
Ascendancy Enters Into Distribution Agreement With EffRx Pharma For Binosto 21
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 22
Licensing Agreements 23
Hikma Pharma Enters Into Licensing Agreement With EffRx Pharma For Binosto 23
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 24
EffRx Pharmaceuticals SA – Key Competitors 25
EffRx Pharmaceuticals SA – Key Employees 26
EffRx Pharmaceuticals SA – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Corporate Communications 28
Jun 01, 2017: Paolo Agnoluzzi Appointed CFO of EffRx Pharmaceuticals 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Key Facts 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EffRx Pharma Raises USD2.3 Million in Venture financing 12
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 13
EffRx Pharma Enters into Agreement with Andrus 15
EffRx Pharma Enters into Distribution Agreement with Andrus for Binosto 16
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 17
EffRx Pharma Enters An Agreement With Kadmon 18
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 19
Lacer Enters Into Distribution Agreement With EffRx For Binosto 20
Ascendancy Enters Into Distribution Agreement With EffRx Pharma For Binosto 21
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 22
Hikma Pharma Enters Into Licensing Agreement With EffRx Pharma For Binosto 23
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 24
EffRx Pharmaceuticals SA, Key Competitors 25
EffRx Pharmaceuticals SA, Key Employees 26

List of Figures
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pinnacle Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia International Corp is a drug development company that develops and markets photodynamic therapy products. The company offers products such as OPTIGUIDE PI, ETHYOL PI, PHOTOFRIN PI, and DIOMED products, among others. Its O …
  • MediaTek Inc.:企業の戦略・SWOT・財務情報
    MediaTek Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaTek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Astellas Pharma US Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astellas Pharma US Inc (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a drug company that offers injections and tablets. The company offers products such as adenosine injections, regadenoson injection, tacrolimus ointment, tacrolimus extended-release capsules, tacrolimus capsules …
  • Vermilion Energy Inc (VET):企業の財務・戦略的SWOT分析
    Summary Vermilion Energy Inc (Vermilion) is an oil and gas company that offers exploration and production services. The company is an oil and gas producer in Alberta. It provides production programs focusing on acquisition, exploration, development and optimization in North America, Europe and Austr …
  • Bangchak Corporation PCL (BCP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bangchak Corporation PCL (Bangchak) is an integrated energy company. Its core business is petroleum refining, procuring crude oil from domestic and international sources and refining it into various petroleum products. The company’s major products include gasoline, gasohol, jet fuel, diesel, …
  • Anchiano Therapeutics Ltd (BICL):製薬・医療:M&Aディール及び事業提携情報
    Summary Anchiano Therapeutics Ltd (Anchiano) formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancer-related diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's produc …
  • Tainergy Tech Co Ltd (4934):電力:M&Aディール及び事業提携情報
    Summary Tainergy Tech Co Ltd (Tainergy) is a renewable energy company that designs, develops, manufactures and markets solar energy products. The company provides products such as solar deionized water systems, multi-crystalline silicon solar cell, standard solar modules, solar module with build in …
  • Medrobotics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Pacific Gas and Electric Co-エネルギー分野:企業M&A・提携分析
    Summary Pacific Gas and Electric Company (PGEC), a subsidiary of PG&E Corporation, is an energy utility, offering electricity and natural gas to its customers. The company carries out generation, transmission and distribution of electricity. PGEC serves residential, commercial, industrial and agricu …
  • Fortum Corp (FORTUM):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • Petronas Dagangan Berhad (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • Aesica Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Aesica Pharmaceuticals Ltd (Aesica), a subsidiary of Consort Medical plc is a contract development and manufacturing organization (CDMO). It manufactures and develops generic active pharmaceutical ingredients (APIs) and finished dosage forms. Aesica’s services portfolio encompass pre-formula …
  • Samchully Co Ltd (004690):企業の財務・戦略的SWOT分析
    Samchully Co Ltd (004690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Georgetown University-製薬・医療分野:企業M&A・提携分析
    Summary Georgetown University (GU) is an academic and research institution which offers educational services. It provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions, special …
  • Schneider Electric SE:企業の戦略・SWOT・財務情報
    Schneider Electric SE - Strategy, SWOT and Corporate Finance Report Summary Schneider Electric SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • WntResearch AB (WNT):製薬・医療:M&Aディール及び事業提携情報
    Summary WntResearch AB (WntResearch) is a biotechnology company that develops novel anti-metastatic therapies for the treatment of cancer. The company's development stage products include Foxy-5 and Box-5. Its lead project, Foxy-5, a peptide which is in Phase I clinical development for reconstitutin …
  • American Greetings Corporation:企業の戦略・SWOT・財務情報
    American Greetings Corporation - Strategy, SWOT and Corporate Finance Report Summary American Greetings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Global Cardiovascular Innovation Center-医療機器分野:企業M&A・提携分析
    Summary Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing adva …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆